1998
DOI: 10.1002/jlb.64.4.563
|View full text |Cite
|
Sign up to set email alerts
|

Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
59
0
8

Year Published

2003
2003
2019
2019

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 64 publications
(69 citation statements)
references
References 25 publications
2
59
0
8
Order By: Relevance
“…25) For instance, lipid body numbers are increased in eosinophils from patients with hypereosinophilic syndrome, 26) in leukocytes from inflammatory arthritis 25) and sepsis, 8) and from bronchoalveolar lavage of patients with acute respiratory distress syndrome, 27,28) Lipid bodies are candidates to play a major role in the formation of eicosanoid mediators during inflammation as they are sites of localization of several enzymes related to eicosanoid metabolism including COX-2, 5-lipoxygenase, phospholipase A2, mitogen-activated protein kinase and phosphatidylinositide 3-kinase. 25,[29][30][31] In addition, agents that inhibit lipid body formation in vitro inhibited the priming response for enhanced eicosanoid release.…”
Section: Discussionmentioning
confidence: 99%
“…25) For instance, lipid body numbers are increased in eosinophils from patients with hypereosinophilic syndrome, 26) in leukocytes from inflammatory arthritis 25) and sepsis, 8) and from bronchoalveolar lavage of patients with acute respiratory distress syndrome, 27,28) Lipid bodies are candidates to play a major role in the formation of eicosanoid mediators during inflammation as they are sites of localization of several enzymes related to eicosanoid metabolism including COX-2, 5-lipoxygenase, phospholipase A2, mitogen-activated protein kinase and phosphatidylinositide 3-kinase. 25,[29][30][31] In addition, agents that inhibit lipid body formation in vitro inhibited the priming response for enhanced eicosanoid release.…”
Section: Discussionmentioning
confidence: 99%
“…PAF-like lipids are potent proinflammatory mediators and seem to be involved on earliest events of atherosclerosis in mice because the PAF receptor antagonist, WEB 2086, decreased monocyte-endothelial interactions and fatty streak formation in LDL receptor-deficient animals fed a lipid-rich diet (19). It is important to note that authentic PAF induces lipid body formation in leukocytes such as neutrophils (20) and eosinophils (21,22). Those lipid bodies are membraneless lipid-rich cytoplasmic inclusions localized in leukocytes and in other inflammation-associated cell types.…”
mentioning
confidence: 99%
“…Diferente dos adipócitos, nos leucócitos a formação de CLs é específica e dependente do estímulo [76][77][78] , do tipo celular [79] e de receptores [77,[80][81][82] . Os CLs são tipicamente escassos em leucócitos não ativados, mas caracteristicamente aumentados em número e tamanho in vitro e in vivo em células inflamatórias [76,[82][83][84][85][86] .…”
Section: Corpúsculos Lipídicos E Sua Inibição Farmacológicaunclassified
“…Trabalhos da literatura já demonstraram uma relação entre a produção inicial de eicosanóides derivados da 5-LO, COX-1 e 2 e a formação CLs in vitro [80,[135][136][137][138][139][140] . Estas são estruturas intracelulares ricas em lipídios não associadas à membrana, cuja indução é específica, dependente do estímulo, [77,80] do tipo celular [79] e do receptor [77,80,94] .…”
Section: Infecção Com As Cepas Sv009 E Sv068 Induz Produção In Vivo Deunclassified
See 1 more Smart Citation